drugset / Trial / NCT04028024
Protective Effect in Cardiac Surgery Patients
NaSingle-groupOpen-labelPrevention
Summary
The purpose of the study was to verify the protective effect of inhibiting systemic inflammatory response in patients undergoing cardiac surgery.
Timeline
- Start
- 2019-08-01
- Primary completion
- 2020-12
- Completion
- 2021-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ulinastatin | Protein / enzyme biologic | 5000 iu/kg | Intravenous |
Indications
No indication recorded.